DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
George S. et al.
Safety and Efficacy of Nivolumab in Patients With Metastatic Renal Cell Carcinoma Treated Beyond Progression: A Subgroup Analysis of a Randomized Clinical Trial.
JAMA Oncol 2016;
2: 1179-1186
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.